ReachRxResearch
Home
Research
Sign Up
T cells in systemic lupus erythematosus: biology and clinical value
Back to Research Hub
  1. Home
  2. Research Hub
  3. T cells in systemic lupus erythematosus:…

T cells in systemic lupus erythematosus: biology and clinical value

Arthritis & Rheumatology·September 25
RheumatologyConfirms priorSystemic Lupus ErythematosusReview ArticleT Cell-Targeted TherapyMixed

Summary

View source

What was studied

The biology of T cell defects in systemic lupus erythematosus (SLE), examining cellular, biochemical, molecular, and metabolic abnormalities and their relevance to disease pathogenesis, biomarkers, personalized medicine, and therapeutic development.

Key findings

Multiple T cell defects in SLE contribute to disease pathogenesis and organ damage, and understanding these abnormalities at various biological levels opens avenues for biomarker development, personalized medicine, and targeted therapeutics.

Study limitations

As a review/perspective article, it does not present original clinical trial data or patient outcomes; conclusions depend on the quality and scope of the studies reviewed.

Clinical implications

Clinicians should be aware that T cell biology in SLE is multifaceted, with defects at cellular, molecular, and metabolic levels that may inform future biomarker use and personalized treatment strategies.

Caveats

  • The clinical applicability of biomarker and personalized medicine proposals discussed may vary, as many referenced approaches are still investigational
  • This is a narrative review; it synthesizes existing literature rather than presenting new primary data, so causal conclusions about T cell defects and SLE outcomes should be interpreted cautiously

Related Questions

Explore related topics

What are the current T cell-targeted therapies being investigated for systemic lupus erythematosus?How do metabolic abnormalities in T cells contribute to lupus disease activity and organ damage?What biomarkers derived from T cell biology are being developed for personalized treatment in SLE?

Publication Details

Year
2026
Journal
Arthritis & Rheumatology
Source
View article
Keep scrolling
More content below.
Up Next